# Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome

Study · id `cardio:ct-nct05389254` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05389254](<https://clinicaltrials.gov/study/NCT05389254>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05389254

Browse, organ or system: Heart; Metabolism  
Browse, condition area: Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05389254. Randomized; no masking; primary purpose treatment. Start 2022-06 (anticipated); primary completion 2023-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05389254, source copy `cardio:ctgov-nct05389254-2022-05-25`, retrieved 2026-10-26)
- Planned start: 2022-06 (anticipated) (ClinicalTrials.gov record NCT05389254, source copy `cardio:ctgov-nct05389254-2022-05-25`, retrieved 2026-10-26)
- Primary completion: 2023-06 (anticipated) (ClinicalTrials.gov record NCT05389254, source copy `cardio:ctgov-nct05389254-2022-05-25`, retrieved 2026-10-26)
- Completion: 2023-12 (anticipated) (ClinicalTrials.gov record NCT05389254, source copy `cardio:ctgov-nct05389254-2022-05-25`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05389254, source copy `cardio:ctgov-nct05389254-2022-05-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05389254-2022-05-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome
- Condition: Type 2 Diabetes Mellitus
- Condition: Acute Coronary Syndrome
- Intervention (Device): continuous glucose monitoring system
- Intervention (Device): capillary blood glucose monitoring
- Lead sponsor: Ningbo No. 1 Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Ningbo No. 1 Hospital (`cardio:org-ningbo-no-1-hospital`)

## Provenance

Content hash: 43b1b245a11886701719a95506fef53130d9e224e4d7b3198ac4cbff74d42ad5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
